NGL Fine-Chem Limited (BOM:524774)
India flag India · Delayed Price · Currency is INR
1,326.00
+1.00 (0.08%)
At close: Jul 11, 2025

NGL Fine-Chem Company Description

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide.

The company offers animal health pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine hcl, s-methoprene, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, carprofen, fenbendazole, and xylazine hydrochloride.

It also offers human health pharmaceutical ingredients comprising of nitazoxanide and atovaquone; and intermediates and specialty chemicals consisting of trimethyl, triazacylononane, and ethyl glucamine.

In addition, the company provides finished dosage forms comprising of diminazene aceturate granules and homidium chloride tablets.

NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

NGL Fine-Chem Limited
Country India
Founded 1981
Industry Medicinal Chemicals and Botanical Products
Employees 682
CEO Rahul Nachane

Contact Details

Address:
301, E Square
Mumbai, 400057
India
Phone 91 22 4084 2222
Website nglfinechem.com

Stock Details

Ticker Symbol 524774
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2833

Key Executives

Name Position
Rahul Nachane Chief Executive Officer
Rajesh Lawande Chief Financial Officer